JosephSDillonMD
Endocrinology • Iowa City, IADiabetes, Lipid Metabolism
Associate Professor, Internal Medicine, University of Iowa College of Medicine
Dr. Dillon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-353-7812Fax+1 319-353-7850
Education & Training
University College of Dublin National Univ SOMClass of 1981
University of Alabama Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
IA State Medical License 1996 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
Publications & Presentations
PubMed
- GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors.Jonathan S Shilyansky, Casandro J Chan, Sophia Xiao, Irena Gribovskaja-Rupp, Dawn E Quelle
Surgery. 2025-03-01 - ASO Author Reflections: The Utility of PRRT upon Progression After Resection and Cytoreduction of GEP-NETs.James R Howe, Scott K Sherman, Joseph S Dillon
Annals of Surgical Oncology. 2025-02-01 - ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors.Luis C Borbon, Scott K Sherman, Patrick J Breheny, Chandrikha Chandrasekharan, Yusuf Menda
Annals of Surgical Oncology. 2025-02-01
Grant Support
- How Does DHEA Improve Diabetic Microvascular DysfunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Dehydroepiandrosterone Sulfate And Insulin SecretionNational Institute On Aging2000–2004
- Molecular Characterization Of The Galanin ReceptorNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Molecular Characterization Of The Galanin ReceptorNational Institute Of Diabetes And Digestive And Kidney Diseases1993–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
